AstraZeneca must prove claim to cheapest COVID-19 vaccine
AstraZeneca had no immediate comment on the matter.
25-year-old Sharon Ben Hemo, a fourth-year student at the Faculty of Dentistry of Hadassah and Hebrew University, receives the IIBR's Brilife vaccine as part of the first phase of human trials in Hadassah University Medical Center, 08.11.2020(photo credit: HADASSAH UNIVERSITY MEDICAL CENTER)ByREUTERS
